The News-Times on MSN
95 people with cancer sue CT's Boehringer Ingelheim over recalled drug Zantac
“[Boehringer Ingelheim] had little incentive to investigate the dangers in a product that was producing over $1 billion in ...
The series of recalls of ranitidine (also known as Zantac) and nizatidine products grew longer with three US Food and Drug Administration (FDA) announcements on Tuesday and Wednesday. The 150 mg and ...
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) is requesting that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market. The ...
CVS Pharmacy announced it’s pulling the heartburn medication Zantac from its shelves over a possible link to cancer. The popular over-the-counter drug and CVS’ own generic brand — ranitidine — will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results